Emmanuelle Vallez
Inserm(FR)Université de Lille(FR)Institut Pasteur de Lille(FR)Centre Hospitalier Universitaire de Lille(FR)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms, Peroxisome Proliferator-Activated Receptors, Adipose Tissue and Metabolism, Diet and metabolism studies
Most-Cited Works
- → Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells(2015)370 cited
- → Tau deletion promotes brain insulin resistance(2017)199 cited
- → Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia(2010)160 cited
- → The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis(2016)128 cited
- → Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects(2017)101 cited
- → Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice(2012)95 cited